Skip to content

Cold Snare Polypectomy Versus. Endoscopic Mucosal Resection

Comparison of Efficacy Between Cold Snare Polypectomy and Endoscopic Mucosal Resection in Treatment of Small Polyp

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02476747
Enrollment
103
Registered
2015-06-19
Start date
2015-06-30
Completion date
2015-10-31
Last updated
2015-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Polyp

Keywords

Colonic polyp

Brief summary

The investigators will investigate the efficacy of EMR compared to CSP in treatment of small colon polp (6\ 10mm). One aim of this study was to investigate the necessity of EMR on resection of small colon polyp.

Detailed description

With sized polyp from 6mm to less than 10mm, it has been classified by the previous studies as a small polyp. Their potential for advanced neoplasia is usually size-dependent, but some recent studies found that, even in diminutive and small polyps, the rate of advanced neoplasia is relatively high about 9%-10%. The investigators will prospectively investigate postprocedural outcomes, such as retrieval rate, procedural time, overall complication rate (Intraprocedural bleeding, postprocedural bleeding, and perforation) in colonoscopic polypectomy of small polyp between CSP and EMR.

Interventions

OTHEREMR

performing EMR for patients with small polyp

OTHERCSP

performing CSP for patients with small polyp

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All those over the age of 20 years who agree informed consent and who have at least one polyp of eligible size (6-10 mm)

Exclusion criteria

* (1) patients taking anticoagulant therapy during the past 1 week of the procedure, (2) known coagulopathy, (3) history of liver cirrhosis, chronic kidney disease, malignancy, inflammatory bowel diseases or significant infectious disease, (4) American Society of Anesthesiology class III or more, and (5) pedunculated polyps and polyps with malignant feature.

Design outcomes

Primary

MeasureTime frame
complete resection rate (CRR)Up to 2 months

Secondary

MeasureTime frame
incidence of complications (Intraprocedural bleeding, postprocedural bleeding, and perforation)Up to 2 months
necessity of hemostasis (due to Intraprocedural bleeding or postprocedural bleeding)Up to 2 months
Polyp retrieval rateUp to 2 months
hospitalization periodUp to 2 months

Countries

South Korea

Contacts

Primary ContactJeong-Sik Byeon, Doctor
jsbyeon@amc.seoul.kr82-2-3010-3905

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026